Consumer healthcare mega merger: Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion cash and stock deal; $1.9 billion cost savings targeted post-merger
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Kimberly-Clark is acquiring Tylenol maker Kenvue for approximately $48.7 billion in a cash-and-stock deal, creating a major consumer health goods company. The combined entity is projected to generate $32 billion in annual net revenues and achieve $1.9 billion in cost savings. Kimberly-Clark's CEO Mike Hsu will lead the merged company, which will retain its Texas headquarters. What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
